Breast tumor stroma: A driving force in the development of resistance to therapies. - Wikidata - wikimedia - TriplyDB

Breast tumor stroma: A driving force in the development of resistance to therapies.

Breast tumor stroma: A driving force in the development of resistance to therapies.

http://www.wikidata.org/entity/Q39064583

about

Stromal Expression of Vimentin Predicts the Clinical Outcome of Stage II Colorectal Cancer for High-Risk Patients.The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer.Resistin potentiates chemoresistance and stemness of breast cancer cells: Implications for racially disparate therapeutic outcomes.Modulating tumor hypoxia by nanomedicine for effective cancer therapy.New insights into antidiabetic drugs: Possible applications in cancer treatment.Combination of nanotechnology with vascular targeting agents for effective cancer therapy.Multiple functions of long non-coding RNAs in oxidative stress, DNA damage response and cancer progression.Nanomedicine applications in the treatment of breast cancer: current state of the art.MicroRNAs Change the Landscape of Cancer Resistance.How Signaling Molecules Regulate Tumor Microenvironment: Parallels to Wound Repair.A Metabolomic Approach to Predict Breast Cancer Behavior and Chemotherapy Response.Prior anti-CAFs break down the CAFs barrier and improve accumulation of docetaxel micelles in tumor Diffusion-weighted MR imaging of locally advanced breast carcinoma: the optimal time window of predicting the early response to neoadjuvant chemotherapy

P2860

Q33821532-02D023C4-63D9-424E-88B9-905DC6A9D503 Q38654867-1B3C08E2-A25C-4477-B915-0DC542D94B2F Q38902610-58A6AC77-A317-49FA-BE58-68B32449BCCE Q38961080-3DF82B43-C64C-4522-B60D-0F5F6CC8E53F Q39272833-4BD8E73D-0B36-4596-8589-2C68DD951BA9 Q39368839-458FF8D9-FED7-45BE-AF80-DA3BECBDC68B Q39368869-C49764C3-5365-40C6-A81C-924AA03FE01C Q41483629-E8BFC998-8196-4FBA-B730-F6BB0C0CD9CA Q46706163-593B38F6-C942-4472-9242-EA5E5C26ACA9 Q47601253-828E4943-15B2-45C0-8458-FB1CC9241F4D Q52692110-E907DF9E-7609-4C1C-8097-0AD9D3C53189 Q57483726-341F915F-D878-4F1A-BEE6-454A252462F8 Q58101662-9EAD6488-6FAB-4666-B2DF-7B3F671F90D1

P2860

Breast tumor stroma: A driving force in the development of resistance to therapies.

http://www.wikidata.org/entity/Q39064583

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Breast tumor stroma: A driving force in the development of resistance to therapies.

@en

Breast tumor stroma: A driving force in the development of resistance to therapies.

@nl

type

label

Breast tumor stroma: A driving force in the development of resistance to therapies.

@en

Breast tumor stroma: A driving force in the development of resistance to therapies.

@nl

prefLabel

Breast tumor stroma: A driving force in the development of resistance to therapies.

@en

Breast tumor stroma: A driving force in the development of resistance to therapies.

@nl

P1433

Q39064583-B5F519E5-5B2F-4836-8680-0E5073A36321

P1476

Q39064583-4824AD15-B014-47B7-8858-C41BEA1EBE8E

P2860

Q39064583-0107430B-FC3A-4293-AE2F-94068107061A

Q39064583-0431B405-669D-4BC1-9806-463A67EB71B3

Q39064583-056C0BC3-2AB7-403A-901B-C436F23DDAB0

Q39064583-0F3A2ACD-CFF1-4BEE-9B66-A204278B5D11

Q39064583-14AD3845-F420-4F59-819A-11DB0E8B5ACE

Q39064583-15FE1992-800C-465F-8541-0A9E174B56F3

Q39064583-188117A2-9F66-4D80-8CB4-C44497FB6FA7

Q39064583-1AA480DB-3846-41D7-96B6-0528CE92C452

Q39064583-1AD2E3D3-7E75-411D-98EC-48708727C2D5

Q39064583-1D3CBE64-AC2E-461A-84CA-2B6E86A086DF

P304

Q39064583-CC6760B6-4EE8-4873-84F8-11F6C48812EC

P31

Q39064583-B37C4AD9-C024-4ABF-B32D-7E36AF27EB9E

P356

Q39064583-FF9F431A-4363-4FC6-94B2-86379B400A08

P433

Q39064583-ACD4E259-2576-4550-AC46-4F6A915CC3C0

P478

Q39064583-54CD032B-0333-4111-AC08-F944BC9C6EE7

P50

Q39064583-C255F732-5DAA-4095-BF5C-CC0757E0FCE7

Q39064583-E76FCD17-04AA-401E-8A62-426141729658

P577

Q39064583-2E009CF3-1866-47C4-80FF-76929EEFFB5C

P698

Q39064583-3D574B28-9954-4B1F-875E-2FE28D14B2AE

P356

P1433

Chemical Biology and Drug Design

P1476

Breast tumor stroma: A driving force in the development of resistance to therapies.

@en

P2860

Microinjection of specific anti-IMPDH2 antibodies induces disassembly of cytoplasmic rods/rings that are primarily stationary and stable structures

Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts

CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3

Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers

Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells

Modes of cancer cell invasion and the role of the microenvironment

Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions

Identifying and targeting tumor-initiating cells in the treatment of breast cancer

Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

P304

309-318

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CBDD.12893

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-01-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28042683

http://www.w3.org/2001/XMLSchema#string